Elan Inks $204M Deal In Zonegran Off-Label Probe
Irish drugmaker Elan Corp. PLC has said it will pay $203.5 million and plead guilty to a misdemeanor criminal charge to settle a federal investigation into its sales and marketing practices...To view the full article, register now.
Already a subscriber? Click here to view full article